Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban PK/PD in ESRD on Hemodialysis
NCT02672709Phase 4Completed
- Sponsor
- Jewish General Hospital
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by Jewish General Hospital. Started Apr 2016; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02672709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02672709.